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STELLINGEN
behorende bij het proefschrift
Endothelial-specic delivery of siRNA by novel SAINT-based lipoplexes
An in vitro and in vivo study
1. Endothelial-specic siRNA delivery presents a promising strategy for anti-
inammatory interventions aiming at silencing disease-associated genes 
involved in the pathophysiology of acute or chronic inammation. (this thesis)
2. PEGylated, antibody targeted SAINT-based lipoplexes (antibody-SAINTPEGargs) 
are suitable devices for selective delivery of siRNA into inammation-activated 
endothelial cells of dierent vascular origins. (this thesis)
3. If all anti-VCAM-1-SAINTPEGargs that homed to VCAM-1 protein expressing 
vasculature in vivo would eectively release their nucleic acid cargo, they would 
be very potent in terms of target gene down-regulation.
4. To design an endothelial-specic siRNA delivery system with true potential for in 
vivo application, evaluating the siRNA delivery systems in a clinically relevant in 
vivo animal model at an early stage in their development is crucial.
5. Despite the eect on carrier size, incorporation of Calf Thymus-DNA in SAINT-
lipoplexes does not result in benecial eects on target gene down-regulation. 
(this thesis)
 
6. RNAi-based therapeutic interventions will be an established therapeutic 
modality when the delivery-related issues have been overcome.
 
7. Negative results have considerably more impact on science than positive results.
8. Do not go where the path may lead, go instead where there is no path and leave 
a trail. (Ralph Waldo Emerson)
9. If we knew what it was we were doing, it would not be called research, would it? 
(Albert Einstein) 
10. “Vrijheid” is een volgetankte Mercedes.
Niek Leus
Groningen, 8 oktober 2014
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